Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Shigeru Ogaki"'
Autor:
Shigeru Ogaki, Kazuaki Taguchi, Hiroshi Watanabe, Ayaka Suenaga, Masaki Otagiri, Toru Maruyama
Publikováno v:
Archives of Pharmacy Practice, Vol 3, Iss 1, Pp 95-95 (2012)
Externí odkaz:
https://doaj.org/article/620b115a863d41c1baa2f4b885cb9c9e
Autor:
Hidehisa Sekijima, Toru Maruyama, Masafumi Fukagawa, Kazuya Ooi, Kento Nishida, Taisei Nagasaki, Masaki Otagiri, Shigeru Ogaki, Kazuaki Matsumoto, Kazuaki Taguchi, Hiroshi Watanabe, Yuki Enoki, Hiroki Yanagisawa, Yu Ishima, Hitoshi Maeda
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 372(3)
Many victims, after being extricated from a collapsed building as the result of a disaster, suffer from disaster nephrology, a term that is referred to as the crush syndrome (CS). Recommended treatments, which include dialysis or the continuous admin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cf5a0184448e2172c773edff845e610
https://pubmed.ncbi.nlm.nih.gov/31924689
https://pubmed.ncbi.nlm.nih.gov/31924689
Autor:
Hiroshi Watanabe, Yu Ishima, Kazuaki Taguchi, Hitoshi Maeda, Toru Maruyama, Masaki Otagiri, Shigeru Ogaki
Publikováno v:
Biochemical Pharmacology. 97:310-319
Red blood cell (RBC) transfusions for controlling hemorrhaging induce systemic ischemia reperfusion, resulting in a decrease in hepatic cytochrome P450 (CYP) levels. Carbon monoxide (CO), when bound to red blood cells (CO-RBC) has the potential to pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09e47faddeed61124023b739d97e7ed3
https://doi.org/10.1016/j.bcp.2015.07.035
https://doi.org/10.1016/j.bcp.2015.07.035
Autor:
Shigeru Ogaki, Yasuo Ikeda, Shinji Takeoka, Kazuaki Taguchi, Mai Hashimoto, Masaki Otagiri, Makoto Handa, Toru Maruyama, Hiroshi Watanabe
Publikováno v:
Journal of Pharmaceutical Sciences. 104:3084-3091
Adenosine diphosphate (ADP)-encapsulated liposomes coated with a fibrinogen γ-chain dodecapeptide [H12 (dodecapeptide ( 400 HHLGGAKQAGDV 411 ))-(ADP)-liposome] is a synthetic platelet substitute, in which the surface is covered with polyethylene gly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0eb5ee9ed6b069c70d3ecddc84b473a9
https://doi.org/10.1002/jps.24418
https://doi.org/10.1002/jps.24418
Publikováno v:
Journal of Pharmaceutical Sciences. 103:2199-2206
Red blood cell (RBC) transfusions are the gold standard in cases of massive hemorrhage, but induce hepatic ischemia-reperfusion injury, a serious complication associated with hemorrhage and RBC resuscitation. Thus, the development of a novel resuscit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92c8ac21d2d61d9c6aea9bac5e3e5f10
https://doi.org/10.1002/jps.24029
https://doi.org/10.1002/jps.24029
Autor:
Yosuke Okamura, Hayato Ujihira, Yasuo Ikeda, Hiroshi Watanabe, Masaki Otagiri, Toru Maruyama, Kazuaki Taguchi, Mami Doi, Shigeru Ogaki, Makoto Handa, Atsushi Fujiyama, Shinji Takeoka
Publikováno v:
Drug Metabolism and Disposition. 41:1584-1591
Fibrinogen γ-chain (dodecapeptide HHLGGAKQAGDV, H12)-coated, ADP-encapsulated liposomes [H12-(ADP)-liposomes] were developed as a synthetic platelet alternative that specifically accumulates at bleeding sites as the result of interactions with activ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3476e71755204cb41df7a46b9e76b35
https://doi.org/10.1124/dmd.112.050005
https://doi.org/10.1124/dmd.112.050005
Publikováno v:
Drug Metabolism and Disposition. 41:141-148
Red blood cell (RBC) transfusions for massive hemorrhage induce systemic ischemic-reperfusion and influence the disposition and pharmacological activity of drugs as a result of a reduction in the level of expression and activity of cytochrome P450s (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f5f4695a1b20d43b75ddace9389fa48
https://doi.org/10.1124/dmd.112.048744
https://doi.org/10.1124/dmd.112.048744
Autor:
Maiko Kaga, Hidenobu Ohta, Hiromi Sakai, Masumi Inagaki, Hitomi Izumi, Kazuaki Taguchi, Kunihiro Okamura, Shigeru Ogaki, Shigeru Tsuchiya, Masaki Otagiri, Heng Li, Nobuo Yaegashi
Publikováno v:
Life Sciences. 91:420-428
Aims Liposome-encapsulated hemoglobin (hemoglobin vesicles: HbV; diameter 250 nm) is reconstructed from human hemoglobin and developed as an artificial oxygen carrier for use as a transfusion alternative. Previous studies using rodent models closely
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12d7706274292cddb44890a8d3915815
https://doi.org/10.1016/j.lfs.2012.08.021
https://doi.org/10.1016/j.lfs.2012.08.021
Autor:
Kazuaki Taguchi, Daisuke Kadowaki, Masaki Otagiri, Hiromi Sakai, Hiroshi Watanabe, Toru Maruyama, Hirohisa Horinouchi, Shigeru Ogaki, Koichi Kobayashi
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 337:201-208
Hemoglobin vesicles (HbVs) could serve as a substitute for red blood cells (RBCs) in resuscitation from massive hemorrhage. A massive transfusion of RBCs can increase the risk of infection, which is not caused by contaminating micro-organisms in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbec6345c2de2b22532d9b785f036424
https://doi.org/10.1124/jpet.110.177832
https://doi.org/10.1124/jpet.110.177832
Autor:
Masaki Otagiri, Kazuaki Taguchi, Manabu Kinoshita, Mai Hashimoto, Kahoko Nishikawa, Toru Maruyama, Yasuo Ikeda, Shinji Takeoka, Hiroshi Watanabe, Shigeru Ogaki, Makoto Handa
Publikováno v:
Journal of pharmaceutical sciences. 104(11)
A preclinical study of dodecapeptide ((400)HHLGGAKQAGDV(411)) (H12)-(adenosine diphosphate, ADP)-liposomes for use as a synthetic platelet (PLT) substitute under conditions of red blood cell (RBC) transfusion-induced dilutional thrombocytopenia is li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f9562d0b6de43323560f8872ccef054
https://pubmed.ncbi.nlm.nih.gov/26249543
https://pubmed.ncbi.nlm.nih.gov/26249543